A detailed history of Wincap Financial LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Wincap Financial LLC holds 8,882 shares of ABBV stock, worth $2.08 Million. This represents 1.39% of its overall portfolio holdings.

Number of Shares
8,882
Previous 8,722 1.83%
Holding current value
$2.08 Million
Previous $2.02 Billion 0.5%
% of portfolio
1.39%
Previous 1.4%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 14, 2026

BUY
$211.96 - $244.38 $33,913 - $39,100
160 Added 1.83%
8,882 $2.03 Billion
Q3 2025

Nov 07, 2025

BUY
$184.85 - $231.54 $44,179 - $55,338
239 Added 2.82%
8,722 $2.02 Billion
Q2 2025

Aug 01, 2025

SELL
$170.16 - $206.27 $36,073 - $43,729
-212 Reduced 2.44%
8,483 $1.57 Billion
Q1 2025

May 07, 2025

BUY
$169.2 - $216.66 $21,319 - $27,299
126 Added 1.47%
8,695 $1.82 Billion
Q4 2024

May 07, 2025

BUY
$164.99 - $203.87 $1.41 Million - $1.75 Million
8,569 New
8,569 $1.52 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $414B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Wincap Financial LLC Portfolio

Follow Wincap Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wincap Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wincap Financial LLC with notifications on news.